Obalon Schedules Second Quarter 2019 Financial Results Conference Call for July 24, 2019 at 8:30 a.m. Eastern Time

July 23, 2019 sandiegobiotech News Comments Off on Obalon Schedules Second Quarter 2019 Financial Results Conference Call for July 24, 2019 at 8:30 a.m. Eastern Time

SAN DIEGO, July 22, 2019 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity,?announces that it plans to release its second quarter 2019 financial results before the market opens on Wednesday, July 24, 2019, and hold a conference call at 8:30 AM Eastern Time (5:30 AM Pacific Time) to discuss the Company’s financial results and provide a business update. Interested parties may access the conference call by dialing (844) 889-7791 (U.S.) or (661) 378-9934 (international) using passcode 1787979. Media and individuals will be in a listen-only mode. Participants are asked to dial in a

Related Articles

No Picture
News

Obalon Announces First Patient Treatments at its First Company-Owned Center for Weight Loss

October 22, 2019 sandiegobiotech News Comments Off on Obalon Announces First Patient Treatments at its First Company-Owned Center for Weight Loss

SAN DIEGO, Oct. 22, 2019 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ:OBLN), a?weight loss solutions company with the first and only?FDA-approved swallowable, gas-filled intra-gastric balloon for non-surgical weight loss,?announces it has tr… […]